Despote the potential for serious consequence and in particular, drug interactions, the use of complementary medicines for people being treated for cancer appears to be very widespread. A recent report in the Australian Journal of Pharmacy focuses attention on two studies presented at the European Society for Medical Oncology (ESMO) 2018 Congress, and provides some interesting insights into the findings from Germany and France.